Drug Report History #270939
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that have changed between versions will be highlighted in yellow, and the changes will be clearly marked as updated.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow, and the change will be clearly marked as updated.
| Field | Version v4-EN | Version v1-EN |
|---|---|---|
| Language | English | English |
| Date Updated | 2025-11-26 (Updated) | 2025-11-03 |
| Drug Identification Number | 02269066 | 02269066 |
| Brand name | LUVERIS | LUVERIS |
| Common or Proper name | Lutropin alfa for injection | Lutropin alfa for injection |
| Company Name | EMD SERONO, A DIVISION OF EMD INC., CANADA | EMD SERONO, A DIVISION OF EMD INC., CANADA |
| Ingredients | LUTROPIN ALFA | LUTROPIN ALFA |
| Strength(s) | 75UNIT | 75UNIT |
| Dosage form(s) | POWDER FOR SOLUTION | POWDER FOR SOLUTION |
| Route of administration | SUBCUTANEOUS SUBCUTANEOUS | SUBCUTANEOUS SUBCUTANEOUS |
| Packaging size | 1 vial | 1 vial |
| Anatomical Therapeutical Chemical (ATC) code | G03GA | G03GA |
| Anatomical Therapeutical Chemical (ATC) description | GONADOTROPHINS AND OTHER OVULATION STIMULANTS | GONADOTROPHINS AND OTHER OVULATION STIMULANTS |
| Reason for shortage | Shortage of an inactive ingredient or component. | Shortage of an inactive ingredient or component. |
| Anticipated start date | ||
| Actual start date | 2025-11-03 | 2025-11-03 |
| Estimated end date | 2025-11-21 | 2025-11-21 |
| Actual end date | 2025-11-26 (Updated) | |
| Shortage status | Actual shortage (Updated) | Anticipated shortage |
| Tier 3 Status | No | No |
| Company comments | water for injection | water for injection |
| Health Canada comments |